Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical and Experimental Metastasis

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 9219723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The future of new pure antiestrogens in clinical breast cancer

  2004cited by this paper
• Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.

  1995cited by this paper
• Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells.

  1995cited by this paper
• Intracellular levels and secretion of insulin-like-growth-factor-binding proteins in MCF-7/6, MCF-7/AZ and MDA-MB-231 breast cancer cells. Differential modulation by estrogens in serum-free medium.

  1995cited by this paper
• Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells.

  1994cited by this paper
• Anti‐proliferative and anti‐estrogenic effects of ICI 164,384 and ICI 182,780 in 4‐OH‐tamoxifen‐resistant human breast‐cancer cells

  1994cited by this paper
• Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls.

  1994cited by this paper
• In vivo stimulation by tamoxifen of cathepsin D RNA level in breast cancer.

  1994cited by this paper
• Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer.

  1994cited by this paper
• Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal.

  1994cited by this paper
• The nude mouse as an in vivo model for human breast cancer invasion and metastasis.

  1993cited by this paper
• MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780.

  1993cited by this paper
• The role of cathepsin D in the invasiveness of human breast cancer cells.

  1993cited by this paper
• A prospective study of the prognostic value of cathepsin D levels in breast cancer cytosol

  1993cited by this paper
• Estrogen and insulin modulation of intracellular insulin-like growth factor binding proteins in human breast cancer cells: possible involvement in lysosomal hydrolases oversecretion.

  1993cited by this paper
• Procathepsin D cannot autoactivate to cathepsin D at acid pH

  1993cited by this paper
• Cathepsin D in breast cancer: a tissue marker associated with metastasis.

  1992cited by this paper
• Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D.

  1992cited by this paper
• Cathepsin D in the malignant progression of neoplastic diseases (review).

  1992cited by this paper
• Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro.

  1991cited by this paper
• Prognostic value of total cathepsin D in breast tumors

  1991cited by this paper
• Regulation of basement membrane invasiveness in human breast cancer model systems.

  1991cited by this paper
• Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.

  1991cited by this paper
• Cathepsin D and prognosis in breast cancer.

  1990cited by this paper
• Cathepsin D: A protease involved in breast cancer metastasis

  1990cited by this paper
• Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

  1989cited by this paper
• Cathepsin D: an independent prognostic factor for metastasis of breast cancer.

  1989cited by this paper
• Peptide mapping by CNBr fragmentation using a sodium dodecyl sulfate-polyacrylamide minigel system.

  1989cited by this paper
• In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.

  1988cited by this paper
• Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border

  1985cited by this paper
• A sensitive procedure for determination of cathepsin D: activity in alveolar and peritoneal macrophages

  1984cited by this paper
• Simple and rapid fluorimetric method for DNA microassay.

  1977cited by this paper
• A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses

  1975cited by this paper
• Increased sialic acid density in surface glycoprotein of transformed and malignant cells--a general phenomenon?

  1973cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Breast Ductal Lavage for Assessment of Breast Cancer Biomarkers

  2010cites this paper
• Quantitative determination and localization of cathepsin D and its inhibitors.

  2009cites this paper
• Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.

  2007cites this paper
• Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines.

  2007cites this paper
• Depletion of procathepsin D gene expression by RNA interference – A potential therapeutic target for breast cancer

  2007cites this paper
• Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells.

  2006cites this paper
• The potentials of MS-based subproteomic approaches in medical science: the case of lysosomes and breast cancer.

  2004cites this paper
• Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: Mediated by the mannose-6-phosphate/IGF-II receptor?

  2004cites this paper
• Oncostatin M induces cell detachment and enhances the metastatic capacity of T-47D human breast carcinoma cells.

  2004cites this paper
• Fibroblasts capture cathepsin D secreted by breast cancer cells: possible role in the regulation of the invasive process.

  2002cites this paper
• Chemotherapeutic drugs change actin skeleton organization and the expression of β-thymosins in human breast cancer cells

  2002cites this paper
• Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model.

  2002cites this paper
• Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.

  2002cites this paper
• Role of procathepsin D activation peptide in prostate cancer growth

  2000cites this paper
• Suppression of breast cancer invasion and migration by indole-3-carbinol: associated with up-regulation of BRCA1 and E-cadherin/catenin complexes

  2000cites this paper
• Secretion of prosaposin, a multifunctional protein, by breast cancer cells.

  1999cites this paper
• Modulation of the estrogen‐regulated proteins cathepsin D and pS2 by opioid agonists in hormone‐sensitive breast cancer cell lines (MCF7 and T47D): Evidence for an interaction between the two systems

  1998cites this paper
• Squamous cell carcinoma of the vulva. Expression of tumor proteases cathepsin-D and pro-cathepsin-L.

  1998cites this paper